Phase I study of single-agent AZD1775 (MK-1775), a wee1 kinase inhibitor, in patients with refractory solid tumors

Khanh Do, Deborah Wilsker, Jiuping Ji, Jennifer Zlott, Tomoko Freshwater, Robert J. Kinders, Jerry Collins, Alice P. Chen, James H. Doroshow, Shivaani Kummar

Research output: Contribution to journalArticlepeer-review

205 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I study of single-agent AZD1775 (MK-1775), a wee1 kinase inhibitor, in patients with refractory solid tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences